isatin has been researched along with Bradykinesia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hamaue, N; Minami, M; Nagashima, K; Ogata, A; Tashiro, K; Terado, M | 1 |
Endo, T; Hamaue, N; Hirafuji, M; Hiroshige, T; Machida, M; Minami, M; Ogata, A; Parvez, SH; Saito, H; Tashiro, K; Terado, M | 1 |
2 other study(ies) available for isatin and Bradykinesia
Article | Year |
---|---|
Isatin, an endogenous MAO inhibitor, improves bradykinesia and dopamine levels in a rat model of Parkinson's disease induced by Japanese encephalitis virus.
Topics: Animals; Brain; Disease Models, Animal; Encephalitis Virus, Japanese; Hypokinesia; Isatin; Monoamine Oxidase Inhibitors; Parkinsonian Disorders; Rats; Rats, Inbred F344; Tyrosine 3-Monooxygenase | 2003 |
Comparative study of the effects of isatin, an endogenous MAO-inhibitor, and selegiline on bradykinesia and dopamine levels in a rat model of Parkinson's disease induced by the Japanese encephalitis virus.
Topics: Animals; Disease Models, Animal; Dopamine; Encephalitis Virus, Japanese; Hypokinesia; Isatin; Mice; Monoamine Oxidase Inhibitors; Parkinson Disease; Rats; Selegiline | 2004 |